MIE Resources, Kingston, RI 02892, USA.
Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):76-82. doi: 10.1002/pds.2063. Epub 2010 Nov 11.
We demonstrated the feasibility of developing national estimates of pediatric inpatient medication use by analyzing data from a large administrative database.
Pediatric inpatient data were extracted from Premier Perspective® database to calculate the prevalence of use of specific medications among hospitalized children in 2008. The database was validated by comparing characteristics to the HCUP KID sample of pediatric hospitalizations for 2006. Prevalence was calculated by categorizing patients as ever or never having received a specific drug.
The 10 drugs administered in the most pediatric hospitalizations were acetaminophen, lidocaine, ampicillin, gentamicin, fentanyl, ibuprofen, morphine, ondansetron, ceftriaxone, and albuterol.
Although the database is not a probability-based sample, it bears sufficient similarity to a probability-based sample of pediatric hospitalizations (HCUP KID) to serve as a starting point in developing national estimates of inpatient pediatric medication use. Over 500 drug entities were administered to hospitalized children, but most are used by small percentages of hospitalized patients. The small numbers of children using any one drug has implications for efforts to study efficacy and safety, describe off-label use, monitor adverse events, describe practice, and conduct comparative effectiveness research.
通过分析来自大型行政数据库的数据,我们展示了开发儿科住院患者用药情况国家估计值的可行性。
从 Premier Perspective®数据库中提取儿科住院患者数据,以计算 2008 年住院儿童特定药物使用的流行率。通过将特征与 2006 年 HCUP KID 儿科住院患者样本进行比较,对数据库进行了验证。通过将患者归类为曾经或从未使用过特定药物,计算了流行率。
在大多数儿科住院患者中使用的 10 种药物为对乙酰氨基酚、利多卡因、氨苄西林、庆大霉素、芬太尼、布洛芬、吗啡、昂丹司琼、头孢曲松和沙丁胺醇。
尽管该数据库不是基于概率的样本,但它与基于概率的儿科住院患者样本(HCUP KID)具有足够的相似性,可以作为开发全国儿科住院患者用药情况国家估计值的起点。超过 500 种药物实体被用于住院儿童,但大多数仅被小比例的住院患者使用。任何一种药物的使用儿童数量较少,这对研究疗效和安全性、描述标签外使用、监测不良事件、描述实践和开展比较效果研究产生了影响。